The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. (Q43243835)
Jump to navigation
Jump to search
scientific article published on 12 November 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. |
scientific article published on 12 November 2009 |
Statements
The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens (English)
Hakan Bozcuk
Sacide Pehlivan
Songül Akcan
Mustafa Pehlivan
Tugce Sever
Mustafa Ozdogan
12 November 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference